Ohya, S., Matsui, M. and Kajikuri, J. 2020. Ca 2+ -Activated K + Channel K Ca 3.1 as a Double-Edged Sword in the Treatment of Inflammatory Bowel Disease. Journal of Gastrointestinal and Liver Diseases. 29, 4 (Dec. 2020), 487–489. DOI:https://doi.org/10.15403/jgld-3234.